Perspective Therapeutics, Inc. (CATX)

NYSEAMERICAN: CATX · Real-Time Price · USD

Compare

2.790

+0.040 (1.45%)

At close: Jan 2, 2026, 4:00 PM EST

2.780

-0.010 (-0.36%)

After-hours: Jan 2, 2026, 5:14 PM EST

Perspective Therapeutics Market Cap

Perspective Therapeutics has a market cap or net worth of $207.4 million as of January 2, 2026. Its market cap has decreased by -11.82% in one year.

Market Cap

207.40M

Enterprise Value

36.21M

1-Year Change

-11.82%

Ranking

#3798

Market Cap Chart

Since April 19, 2007, Perspective Therapeutics's market cap has increased from $65.60M to $207.40M, an increase of 216.16%. That is a compound annual growth rate of 6.34%.

Market Cap History

Date	Market Cap	% Change
Dec 31, 2025	204.40M	-5.19%
Dec 31, 2024	215.60M	91.13%
Dec 29, 2023	112.80M	221.37%
Dec 30, 2022	35.10M	-36.18%
Dec 31, 2021	55.00M	39.95%
Dec 31, 2020	39.30M	-6.65%
Dec 31, 2019	42.10M	108.42%
Dec 31, 2018	20.20M	-8.18%
Dec 29, 2017	22.00M	-31.03%
Dec 30, 2016	31.90M	-38.18%
Dec 31, 2015	51.60M	-35.58%
Dec 31, 2014	80.10M	317.19%
Dec 31, 2013	19.20M	-28.89%
Dec 31, 2012	27.00M	41.36%
Dec 30, 2011	19.10M	-28.20%
Dec 31, 2010	26.60M	30.39%
Dec 31, 2009	20.40M	343.48%
Dec 31, 2008	4.60M	-90.09%
Dec 31, 2007	46.40M	-29.27%
Apr 19, 2007	65.60M	-

View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	962.25B
Johnson & Johnson	498.60B
AbbVie	403.83B
UnitedHealth Group	299.03B
AstraZeneca	287.81B
Novartis AG	266.00B
Merck & Co.	261.26B
Novo Nordisk	227.63B

Market Cap Rankings